{
    "abstract": "Neisseria meningitidis (Nm) and N. gonorrhoeae (Ng) express a Macrophage Infectivity Potentiator (MIP, NMB1567/NEIS1487) protein in their outer membrane (OM). In this study, we prepared independent batches of liposomes (n = 3) and liposomes + MonoPhosphoryl Lipid A (MPLA) (n = 3) containing recombinant truncated Nm-MIP protein encoded by Allele 2 (rT-Nm-MIP, amino acids 22\u2013142), and used these to immunize mice. We tested the hypothesis that independent vaccine batches showed similar antigenicity, and that antisera could recognise both meningococcal and gonococcal MIP and induce cross-species bactericidal activity. The different batches of M2 rT-Nm-MIP-liposomes \u00b1 MPLA showed no significant (P > 0.05) batch-to-batch variation in antigenicity. Anti-rT-Nm-MIP sera reacted equally and specifically with Nm-MIP and Ng-MIP in OM and on live bacterial cell surfaces. Specificity was shown by no antiserum reactivity with \u0394mip bacteria. Using human complement/serum bactericidal assays, anti-M2 rT-Nm-MIP sera killed homologous meningococcal serogroup B (MenB) strains (median titres of 32\u201364 for anti-rT-Nm-MIP-liposome sera; 128\u2013256 for anti-rT-Nm-MIP-liposome + MPLA sera) and heterologous M1 protein-expressing MenB strains (titres of 64 for anti rT-Nm-MIP-liposome sera; 128\u2013256 for anti-rT-Nm-MIP-liposome + MPLA sera). Low-level killing (P < 0.05) was observed for a MenB isolate expressing M7 protein (titres 4\u20138), but MenB strains expressing M6 protein were not killed (titre < 4\u20138). Killing (P < 0.05) was observed against MenC and MenW bacteria expressing homologous M2 protein (titres of 8\u201316) but not against MenA or MenY bacteria (titres < 4\u20138). Antisera to M2 rT-Nm-MIP showed significant (P < 0.05) cross-bactericidal activity against gonococcal strain P9-17 (expressing M35 Ng-MIP, titres of 64\u2013512) and strain 12CFX_T_003 (expressing M10 Ng-MIP, titres 8\u201316) but not against FA1090 (expressing M8 Ng-MIP). As an alternative to producing recombinant protein, we engineered successfully the Nm-OM to express M2 Truncated\u2013Nm-MIP, but lipooligosaccharide-extraction with Na-DOC was contra-indicated. Our data suggest that a multi-component vaccine containing a select number of Nm- and Ng-MIP type proteins would be required to provide broad coverage of both pathogens.",
    "author_highlights": [
        {
            "endOffset": 23920,
            "sentence": "Antigenicity of rT-N.",
            "startOffset": 23899
        },
        {
            "endOffset": 23978,
            "sentence": "meningitidis-MIP vaccine batches is reproducible in mice.",
            "startOffset": 23921
        },
        {
            "endOffset": 24059,
            "sentence": "Antibodies to rT-Nm-MIP cross-react with surface Ng-MIP and adhere to gonococci.",
            "startOffset": 23979
        },
        {
            "endOffset": 24119,
            "sentence": "Antisera to rT-Nm-MIP are cross-bactericidal for gonococci.",
            "startOffset": 24060
        },
        {
            "endOffset": 24175,
            "sentence": "Meningococcal OM can be engineered to express T-Nm-MIP.",
            "startOffset": 24120
        }
    ],
    "bib_entries": {
        "b0005": {
            "authors": [
                {
                    "first": "Nadine G.",
                    "initial": "N.G.",
                    "last": "Rouphael"
                },
                {
                    "first": "David S.",
                    "initial": "D.S.",
                    "last": "Stephens"
                }
            ],
            "doi": "10.1007/978-1-61779-346-2_1",
            "firstpage": "1",
            "issn": "10643745",
            "lastpage": "20",
            "pmid": "21993636",
            "pub_year": 2012,
            "title": "Neisseria meningitidis: Biology, microbiology, and epidemiology",
            "volume": "799"
        },
        "b0010": {
            "authors": [
                {
                    "first": "Ann E.",
                    "initial": "A.E.",
                    "last": "Jerse"
                },
                {
                    "first": "Carolyn D.",
                    "initial": "C.D.",
                    "last": "Deal"
                }
            ],
            "doi": "10.1136/sextrans-2013-051225",
            "firstpage": "iv63",
            "issn": "13684973",
            "lastpage": "iv68",
            "pmid": "24243883",
            "pub_year": 2013,
            "title": "Vaccine research for gonococcal infections: Where are we?",
            "volume": "89"
        },
        "b0015": {
            "authors": [
                {
                    "first": "Mairi",
                    "initial": "M.",
                    "last": "Vella"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Pace"
                }
            ],
            "doi": "10.1517/14712598.2015.993375",
            "firstpage": "529",
            "issn": "14712598",
            "lastpage": "546",
            "pmid": "25496172",
            "pub_year": 2015,
            "title": "Glycoconjugate vaccines: An update",
            "volume": "15"
        },
        "b0020": {
            "authors": [
                {
                    "first": "Kathleen",
                    "initial": "K.",
                    "last": "Tiffay"
                },
                {
                    "first": "Luis",
                    "initial": "L.",
                    "last": "Jodar"
                },
                {
                    "first": "Marie Paule",
                    "initial": "M.P.",
                    "last": "Kieny"
                },
                {
                    "first": "Muriel",
                    "initial": "M.",
                    "last": "Socquet"
                },
                {
                    "first": "F. Marc",
                    "initial": "F.M.",
                    "last": "La Force"
                }
            ],
            "doi": "10.1093/cid/civ594",
            "firstpage": "S396",
            "issn": "10584838",
            "lastpage": "S403",
            "pmid": "26553666",
            "pub_year": 2015,
            "title": "The evolution of the meningitis vaccine project",
            "volume": "61"
        },
        "b0025": {
            "authors": [
                {
                    "first": "Matt",
                    "initial": "M.",
                    "last": "Shirley"
                },
                {
                    "first": "Sohita",
                    "initial": "S.",
                    "last": "Dhillon"
                }
            ],
            "doi": "10.1007/s40259-015-0139-0",
            "firstpage": "353",
            "issn": "11738804",
            "lastpage": "361",
            "pmid": "26394633",
            "pub_year": 2015,
            "title": "Bivalent rLP2086 Vaccine (Trumenba\u00ae): A Review in Active Immunization Against Invasive Meningococcal Group B Disease in Individuals Aged 10-25 Years",
            "volume": "29"
        },
        "b0030": {
            "authors": [
                {
                    "first": "Philip S.",
                    "initial": "P.S.",
                    "last": "Watson"
                },
                {
                    "first": "David P.J.",
                    "initial": "D.P.J.",
                    "last": "Turner"
                }
            ],
            "doi": "10.1016/j.vaccine.2015.11.057",
            "firstpage": "875",
            "issn": "0264410X",
            "lastpage": "880",
            "pmid": "26686570",
            "pub_year": 2016,
            "title": "Clinical experience with the meningococcal B vaccine, Bexsero\u00ae: Prospects for reducing the burden of meningococcal serogroup B disease",
            "volume": "34"
        },
        "b0035": {
            "authors": [
                {
                    "first": "Sydel R.",
                    "initial": "S.R.",
                    "last": "Parikh"
                },
                {
                    "first": "Nick J.",
                    "initial": "N.J.",
                    "last": "Andrews"
                },
                {
                    "first": "Kazim",
                    "initial": "K.",
                    "last": "Beebeejaun"
                },
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Campbell"
                },
                {
                    "first": "Sonia",
                    "initial": "S.",
                    "last": "Ribeiro"
                },
                {
                    "first": "Charlotte",
                    "initial": "C.",
                    "last": "Ward"
                },
                {
                    "first": "Joanne M.",
                    "initial": "J.M.",
                    "last": "White"
                },
                {
                    "first": "Ray",
                    "initial": "R.",
                    "last": "Borrow"
                },
                {
                    "first": "Mary E.",
                    "initial": "M.E.",
                    "last": "Ramsay"
                },
                {
                    "first": "Shamez N.",
                    "initial": "S.N.",
                    "last": "Ladhani"
                }
            ],
            "doi": "10.1016/S0140-6736(16)31921-3",
            "firstpage": "2775",
            "issn": "01406736",
            "lastpage": "2782",
            "pmid": "28100432",
            "pub_year": 2016,
            "title": "Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort study",
            "volume": "388"
        },
        "b0040": null,
        "b0045": {
            "authors": [
                {
                    "first": "Magnus",
                    "initial": "M.",
                    "last": "Unemo"
                },
                {
                    "first": "Carlos",
                    "initial": "C.",
                    "last": "Del Rio"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Shafer"
                }
            ],
            "doi": "10.1128/microbiolspec.EI10-0009-2015",
            "issn": "21650497",
            "pmid": "27337478",
            "pub_year": 2016,
            "title": "Antimicrobial resistance expressed by Neisseria gonorrhoeae: A major global public health problem in the 21st century",
            "volume": "4"
        },
        "b0050": {
            "authors": [
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Shafer"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Ann E.",
                    "initial": "A.E.",
                    "last": "Jerse"
                }
            ],
            "doi": "10.1146/annurev-micro-090816-093530",
            "firstpage": "665",
            "issn": "00664227",
            "lastpage": "686",
            "pmid": "28886683",
            "pub_year": 2017,
            "title": "Neisseria gonorrhoeae: Drug Resistance, Mouse Models, and Vaccine Development",
            "volume": "71"
        },
        "b0055": {
            "authors": [
                {
                    "first": "Lee M.",
                    "initial": "L.M.",
                    "last": "Wetzler"
                },
                {
                    "first": "Ian M.",
                    "initial": "I.M.",
                    "last": "Feavers"
                },
                {
                    "first": "Scott D.",
                    "initial": "S.D.",
                    "last": "Gray-Owen"
                },
                {
                    "first": "Ann E.",
                    "initial": "A.E.",
                    "last": "Jerse"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                },
                {
                    "first": "Carolyn D.",
                    "initial": "C.D.",
                    "last": "Deal"
                }
            ],
            "doi": "10.1128/CVI.00230-16",
            "firstpage": "656",
            "issn": "15566811",
            "lastpage": "663",
            "pmid": "27335384",
            "pub_year": 2016,
            "title": "Summary and recommendations from the National Institute of Allergy and Infectious Diseases (NIAID) workshop \"Gonorrhea Vaccines: The Way forward\"",
            "volume": "23"
        },
        "b0060": {
            "authors": [
                {
                    "first": "S. F.",
                    "initial": "S.F.",
                    "last": "G\u00f6thel"
                },
                {
                    "first": "M. A.",
                    "initial": "M.A.",
                    "last": "Marahiel"
                }
            ],
            "doi": "10.1007/s000180050299",
            "firstpage": "423",
            "issn": "1420682X",
            "lastpage": "436",
            "pmid": "10228556",
            "pub_year": 1999,
            "title": "Peptidyl-prolyl cis-trams isomerases, a superfamily of ubiquitous folding catalysts",
            "volume": "55"
        },
        "b0065": {
            "authors": [
                {
                    "first": "Mar\u00eda Victoria",
                    "initial": "M.V.",
                    "last": "Humbert"
                },
                {
                    "first": "Hannia L.",
                    "initial": "H.L.",
                    "last": "Almonacid Mendoza"
                },
                {
                    "first": "Alexandra C.",
                    "initial": "A.C.",
                    "last": "Jackson"
                },
                {
                    "first": "Miao Chiu",
                    "initial": "M.C.",
                    "last": "Hung"
                },
                {
                    "first": "Magdalena K.",
                    "initial": "M.K.",
                    "last": "Bielecka"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                }
            ],
            "doi": "10.1586/14760584.2015.1095638",
            "firstpage": "1633",
            "issn": "14760584",
            "lastpage": "1649",
            "pmid": "26468663",
            "pub_year": 2015,
            "title": "Vaccine potential of bacterial macrophage infectivity potentiator (MIP)-like peptidyl prolyl cis/trans isomerase (PPIase) proteins",
            "volume": "14"
        },
        "b0070": {
            "authors": [
                {
                    "first": "Hebert",
                    "initial": "H.",
                    "last": "Echenique-Rivera"
                },
                {
                    "first": "Alessandro",
                    "initial": "A.",
                    "last": "Muzzi"
                },
                {
                    "first": "Elena",
                    "initial": "E.",
                    "last": "Del Tordello"
                },
                {
                    "first": "Kate L.",
                    "initial": "K.L.",
                    "last": "Seib"
                },
                {
                    "first": "Patrice",
                    "initial": "P.",
                    "last": "Francois"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Davide",
                    "initial": "D.",
                    "last": "Serruto"
                }
            ],
            "doi": "10.1371/journal.ppat.1002027",
            "issn": "15537366",
            "pmid": "21589640",
            "pub_year": 2011,
            "title": "Transcriptome analysis of Neisseria meningitidis in human whole blood and mutagenesis studies identify virulence factors involved in blood survival",
            "volume": "7"
        },
        "b0075": {
            "authors": [
                {
                    "first": "Anastasija",
                    "initial": "A.",
                    "last": "Reimer"
                },
                {
                    "first": "Florian",
                    "initial": "F.",
                    "last": "Seufert"
                },
                {
                    "first": "Matthias",
                    "initial": "M.",
                    "last": "Weiwad"
                },
                {
                    "first": "Jutta",
                    "initial": "J.",
                    "last": "Ebert"
                },
                {
                    "first": "Nicole M.",
                    "initial": "N.M.",
                    "last": "Bzdyl"
                },
                {
                    "first": "Charlene M.",
                    "initial": "C.M.",
                    "last": "Kahler"
                },
                {
                    "first": "Mitali",
                    "initial": "M.",
                    "last": "Sarkar-Tyson"
                },
                {
                    "first": "Ulrike",
                    "initial": "U.",
                    "last": "Holzgrabe"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Rudel"
                },
                {
                    "first": "Vera",
                    "initial": "V.",
                    "last": "Kozjak-Pavlovic"
                }
            ],
            "doi": "10.1016/j.ijantimicag.2016.06.020",
            "firstpage": "401",
            "issn": "09248579",
            "lastpage": "408",
            "pmid": "27516227",
            "pub_year": 2016,
            "title": "Inhibitors of macrophage infectivity potentiator-like PPIases affect neisserial and chlamydial pathogenicity",
            "volume": "48"
        },
        "b0080": {
            "authors": [
                {
                    "first": "Magdalena K.",
                    "initial": "M.K.",
                    "last": "Bielecka"
                },
                {
                    "first": "Nathalie",
                    "initial": "N.",
                    "last": "Devos"
                },
                {
                    "first": "M\u00e9lanie",
                    "initial": "M.",
                    "last": "Gilbert"
                },
                {
                    "first": "Miao Chiu",
                    "initial": "M.C.",
                    "last": "Hung"
                },
                {
                    "first": "Vincent",
                    "initial": "V.",
                    "last": "Weynants"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                }
            ],
            "doi": "10.1128/IAI.01815-14",
            "firstpage": "730",
            "issn": "00199567",
            "lastpage": "742",
            "pmid": "25452551",
            "pub_year": 2015,
            "title": "Recombinant protein truncation strategy for inducing bactericidal antibodies to the macrophage infectivity potentiator protein of Neisseria meningitidis and circumventing potential cross-reactivity with human FK506-binding proteins",
            "volume": "83"
        },
        "b0085": {
            "authors": [
                {
                    "first": "Miao Chiu",
                    "initial": "M.C.",
                    "last": "Hung"
                },
                {
                    "first": "Omar",
                    "initial": "O.",
                    "last": "Salim"
                },
                {
                    "first": "Jeannette N.",
                    "initial": "J.N.",
                    "last": "Williams"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                }
            ],
            "doi": "10.1128/IAI.05019-11",
            "firstpage": "3784",
            "issn": "00199567",
            "lastpage": "3791",
            "pmid": "21708989",
            "pub_year": 2011,
            "title": "The Neisseria meningitidis macrophage infectivity potentiator protein induces cross-strain serum bactericidal activity and is a potential serogroup B vaccine candidate",
            "volume": "79"
        },
        "b0090": {
            "authors": [
                {
                    "first": "Rosanna",
                    "initial": "R.",
                    "last": "Leuzzi"
                },
                {
                    "first": "Laura",
                    "initial": "L.",
                    "last": "Serino"
                },
                {
                    "first": "Maria",
                    "initial": "M.",
                    "last": "Scarselli"
                },
                {
                    "first": "Silvana",
                    "initial": "S.",
                    "last": "Savino"
                },
                {
                    "first": "Maria Rita",
                    "initial": "M.R.",
                    "last": "Fontana"
                },
                {
                    "first": "Elisabetta",
                    "initial": "E.",
                    "last": "Monaci"
                },
                {
                    "first": "Annarita",
                    "initial": "A.",
                    "last": "Taddei"
                },
                {
                    "first": "Gunter",
                    "initial": "G.",
                    "last": "Fischer"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                }
            ],
            "doi": "10.1111/j.1365-2958.2005.04859.x",
            "firstpage": "669",
            "issn": "0950382X",
            "lastpage": "681",
            "pmid": "16238618",
            "pub_year": 2005,
            "title": "Ng-MIP, a surface-exposed lipoprotein of Neisseria gonorrhoeae, has a peptidyl-prolyl cis/trans isomerase (PPlase) activity and is involved in persistence in macrophages",
            "volume": "58"
        },
        "b0095": {
            "authors": [
                {
                    "first": "Stefania",
                    "initial": "S.",
                    "last": "Starnino"
                },
                {
                    "first": "Rosanna",
                    "initial": "R.",
                    "last": "Leuzzi"
                },
                {
                    "first": "Valeria",
                    "initial": "V.",
                    "last": "Ghisetti"
                },
                {
                    "first": "Maria Antonia",
                    "initial": "M.A.",
                    "last": "De Francesco"
                },
                {
                    "first": "Marco",
                    "initial": "M.",
                    "last": "Cusini"
                },
                {
                    "first": "Giampaolo",
                    "initial": "G.",
                    "last": "Impara"
                },
                {
                    "first": "Emma",
                    "initial": "E.",
                    "last": "Galluppi"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Paola",
                    "initial": "P.",
                    "last": "Stefanelli"
                }
            ],
            "firstpage": "167",
            "issn": "11217138",
            "lastpage": "170",
            "pmid": "20518279",
            "pub_year": 2010,
            "title": "Molecular analysis of two novel Neisseria gonorrhoeae virulent components: The macrophage infectivity potentiator and the outer membrane protein A",
            "volume": "33"
        },
        "b0100": {
            "authors": [
                {
                    "first": "W. D.",
                    "initial": "W.D.",
                    "last": "Zollinger"
                },
                {
                    "first": "R. E.",
                    "initial": "R.E.",
                    "last": "Mandrell"
                }
            ],
            "firstpage": "257",
            "issn": "00199567",
            "lastpage": "264",
            "pmid": "6403466",
            "pub_year": 1983,
            "title": "Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningococcal group B polysaccharide",
            "volume": "40"
        },
        "b0105": {
            "authors": [
                {
                    "first": "C. J.",
                    "initial": "C.J.",
                    "last": "Gill"
                },
                {
                    "first": "S.",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "J. A.",
                    "initial": "J.A.",
                    "last": "Welsch"
                },
                {
                    "first": "L.",
                    "initial": "L.",
                    "last": "De Tora"
                },
                {
                    "first": "A.",
                    "initial": "A.",
                    "last": "Anemona"
                }
            ],
            "doi": "10.1016/j.vaccine.2011.10.068",
            "firstpage": "29",
            "issn": "0264410X",
            "lastpage": "34",
            "pmid": "22075087",
            "pub_year": 2011,
            "title": "Correlation between serum bactericidal activity against Neisseria meningitidis serogroups A, C, W-135 and Y measured using human versus rabbit serum as the complement source",
            "volume": "30"
        },
        "b0110": {
            "authors": [
                {
                    "first": "Charlotte",
                    "initial": "C.",
                    "last": "Brookes"
                },
                {
                    "first": "Eeva",
                    "initial": "E.",
                    "last": "Kuisma"
                },
                {
                    "first": "Frances",
                    "initial": "F.",
                    "last": "Alexander"
                },
                {
                    "first": "Lauren",
                    "initial": "L.",
                    "last": "Allen"
                },
                {
                    "first": "Thomas",
                    "initial": "T.",
                    "last": "Tipton"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Andrew",
                    "initial": "A.",
                    "last": "Gorringe"
                },
                {
                    "first": "Stephen",
                    "initial": "S.",
                    "last": "Taylor"
                }
            ],
            "doi": "10.1016/j.jim.2013.02.007",
            "firstpage": "39",
            "issn": "00221759",
            "lastpage": "49",
            "pmid": "23485926",
            "pub_year": 2013,
            "title": "Development of a large scale human complement source for use in bacterial immunoassays",
            "volume": "391"
        },
        "b0115": {
            "authors": [
                {
                    "first": "Jeannette N.",
                    "initial": "J.N.",
                    "last": "Williams"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Skipp"
                },
                {
                    "first": "C. David",
                    "initial": "C.D.",
                    "last": "O'Connor"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                }
            ],
            "doi": "10.1128/IAI.00701-09",
            "firstpage": "5080",
            "issn": "00199567",
            "lastpage": "5089",
            "pmid": "19737898",
            "pub_year": 2009,
            "title": "Immunoproteomic analysis of the development of natural immunity in subjects colonized by Neisseria meningitidis reveals potential vaccine candidates",
            "volume": "77"
        },
        "b0120": {
            "authors": [
                {
                    "first": "H.",
                    "initial": "H.",
                    "last": "De la Paz"
                },
                {
                    "first": "S. J.",
                    "initial": "S.J.",
                    "last": "Cooke"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                }
            ],
            "firstpage": "913",
            "issn": "13500872",
            "lastpage": "920",
            "pmid": "7539687",
            "pub_year": 1995,
            "title": "Effect of sialylation of lipopolysaccharide of Neisseria gonorrhoeae on recognition and complement-mediated killing by monoclonal antibodies directed against different outer-membrane antigens",
            "volume": "141"
        },
        "b0125": {
            "authors": [
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                }
            ],
            "doi": "10.1099/00221287-99-2-333",
            "firstpage": "333",
            "issn": "00221287",
            "lastpage": "341",
            "pmid": "406355",
            "pub_year": 1977,
            "title": "The surface properties of Neisseria gonorrhoeae: isolation of the major components of the outer membrane",
            "volume": "99"
        },
        "b0130": {
            "authors": [
                {
                    "first": "Jeannette N.",
                    "initial": "J.N.",
                    "last": "Williams"
                },
                {
                    "first": "Paul J.",
                    "initial": "P.J.",
                    "last": "Skipp"
                },
                {
                    "first": "Holly E.",
                    "initial": "H.E.",
                    "last": "Humphries"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                },
                {
                    "first": "C. David",
                    "initial": "C.D.",
                    "last": "O'Connor"
                },
                {
                    "first": "John E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                }
            ],
            "doi": "10.1128/IAI.01424-06",
            "firstpage": "1364",
            "issn": "00199567",
            "lastpage": "1372",
            "pmid": "17158897",
            "pub_year": 2007,
            "title": "Proteomic analysis of outer membranes and vesicles from wild-type serogroup B Neisseria meningitidis and a lipopolysaccharide-deficient mutant",
            "volume": "75"
        },
        "b0135": {
            "authors": [
                {
                    "first": "Rolando",
                    "initial": "R.",
                    "last": "Pajon"
                },
                {
                    "first": "Andrew M.",
                    "initial": "A.M.",
                    "last": "Fergus"
                },
                {
                    "first": "Dan M.",
                    "initial": "D.M.",
                    "last": "Granoff"
                }
            ],
            "doi": "10.1371/journal.pone.0066536",
            "issn": "19326203",
            "pmid": "23805230",
            "pub_year": 2013,
            "title": "Mutant Native Outer Membrane Vesicles Combined with a Serogroup A Polysaccharide Conjugate Vaccine for Prevention of Meningococcal Epidemics in Africa",
            "volume": "8"
        },
        "b0140": {
            "authors": [
                {
                    "first": "E. A.",
                    "initial": "E.A.",
                    "last": "Stohl"
                },
                {
                    "first": "H. S.",
                    "initial": "H.S.",
                    "last": "Seifert"
                }
            ],
            "doi": "10.1046/j.1365-2958.2001.02463.x",
            "firstpage": "1301",
            "issn": "0950382X",
            "lastpage": "1310",
            "pmid": "11442829",
            "pub_year": 2001,
            "title": "The recX gene potentiates homologous recombination in Neisseria gonorrhoeae",
            "volume": "40"
        },
        "b0145": {
            "authors": [
                {
                    "first": "M.",
                    "initial": "M.",
                    "last": "Christodoulides"
                },
                {
                    "first": "B. T.",
                    "initial": "B.T.",
                    "last": "McGuinness"
                },
                {
                    "first": "J. E.",
                    "initial": "J.E.",
                    "last": "Heckels"
                }
            ],
            "doi": "10.1099/00221287-139-8-1729",
            "firstpage": "1729",
            "issn": "00221287",
            "lastpage": "1738",
            "pmid": "7691983",
            "pub_year": 1993,
            "title": "Immunization with synthetic peptides containing epitopes of the class 1 outer-membrane protein of Neisseria meningitidis: Production of bactericidal antibodies on immunization with a cyclic peptide",
            "volume": "139"
        },
        "b0150": {
            "authors": [
                {
                    "first": "Mar\u00eda Victoria",
                    "initial": "M.V.",
                    "last": "Humbert"
                },
                {
                    "first": "Miao Chiu",
                    "initial": "M.C.",
                    "last": "Hung"
                },
                {
                    "first": "Renee",
                    "initial": "R.",
                    "last": "Phillips"
                },
                {
                    "first": "Charlene",
                    "initial": "C.",
                    "last": "Akoto"
                },
                {
                    "first": "Alison",
                    "initial": "A.",
                    "last": "Hill"
                },
                {
                    "first": "Wei Ming",
                    "initial": "W.M.",
                    "last": "Tan"
                },
                {
                    "first": "John Edward",
                    "initial": "J.E.",
                    "last": "Heckels"
                },
                {
                    "first": "Myron",
                    "initial": "M.",
                    "last": "Christodoulides"
                }
            ],
            "doi": "10.1371/journal.pone.0160403",
            "issn": "19326203",
            "pmid": "27505005",
            "pub_year": 2016,
            "title": "Vaccine potential and diversity of the putative cell binding factor (CBF, NMB0345/NEIS1825) protein of Neisseria meningitidis",
            "volume": "11"
        },
        "b0155": {
            "authors": [
                {
                    "first": "Sunita",
                    "initial": "S.",
                    "last": "Gulati"
                },
                {
                    "first": "Bo",
                    "initial": "B.",
                    "last": "Zheng"
                },
                {
                    "first": "George W.",
                    "initial": "G.W.",
                    "last": "Reed"
                },
                {
                    "first": "Xiaohong",
                    "initial": "X.",
                    "last": "Su"
                },
                {
                    "first": "Andrew D.",
                    "initial": "A.D.",
                    "last": "Cox"
                },
                {
                    "first": "Frank",
                    "initial": "F.",
                    "last": "St. Michael"
                },
                {
                    "first": "Jacek",
                    "initial": "J.",
                    "last": "Stupak"
                },
                {
                    "first": "Lisa A.",
                    "initial": "L.A.",
                    "last": "Lewis"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                }
            ],
            "doi": "10.1371/journal.ppat.1003559",
            "issn": "15537366",
            "pmid": "24009500",
            "pub_year": 2013,
            "title": "Immunization against a Saccharide Epitope Accelerates Clearance of Experimental Gonococcal Infection",
            "volume": "9"
        },
        "b0160": {
            "authors": [
                {
                    "first": "Keith A.",
                    "initial": "K.A.",
                    "last": "Jolley"
                },
                {
                    "first": "Martin C.J.",
                    "initial": "M.C.J.",
                    "last": "Maiden"
                }
            ],
            "doi": "10.1186/1471-2105-11-595",
            "issn": "14712105",
            "pmid": "21143983",
            "pub_year": 2010,
            "title": "BIGSdb: Scalable analysis of bacterial genome variation at the population level",
            "volume": "11"
        },
        "b0165": {
            "authors": [
                {
                    "first": "John A.",
                    "initial": "J.A.",
                    "last": "Bogdan"
                },
                {
                    "first": "C. A.S.A.",
                    "initial": "C.A.S.A.",
                    "last": "Minetti"
                },
                {
                    "first": "M. S.",
                    "initial": "M.S.",
                    "last": "Blake"
                }
            ],
            "doi": "10.1016/S0167-7012(01)00364-5",
            "firstpage": "97",
            "issn": "01677012",
            "lastpage": "101",
            "pmid": "11777587",
            "pub_year": 2002,
            "title": "A one-step method for genetic transformation of non-piliated Neisseria meningitidis",
            "volume": "49"
        },
        "b0170": {
            "authors": [
                {
                    "first": "Lis A.",
                    "initial": "L.A.",
                    "last": "Lewis"
                },
                {
                    "first": "William M.",
                    "initial": "W.M.",
                    "last": "Shafer"
                },
                {
                    "first": "Tathagat Dutta",
                    "initial": "T.D.",
                    "last": "Ray"
                },
                {
                    "first": "Sanjay",
                    "initial": "S.",
                    "last": "Ram"
                },
                {
                    "first": "Peter A.",
                    "initial": "P.A.",
                    "last": "Rice"
                }
            ],
            "doi": "10.1128/IAI.00751-12",
            "firstpage": "33",
            "issn": "00199567",
            "lastpage": "42",
            "pmid": "23071134",
            "pub_year": 2013,
            "title": "Phosphoethanolamine residues on the lipid a moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing",
            "volume": "81"
        },
        "b0175": {
            "authors": [
                {
                    "first": "Daniela",
                    "initial": "D.",
                    "last": "Toneatto"
                },
                {
                    "first": "Mariagrazia",
                    "initial": "M.",
                    "last": "Pizza"
                },
                {
                    "first": "Vega",
                    "initial": "V.",
                    "last": "Masignani"
                },
                {
                    "first": "Rino",
                    "initial": "R.",
                    "last": "Rappuoli"
                }
            ],
            "doi": "10.1080/14760584.2017.1308828",
            "firstpage": "433",
            "issn": "14760584",
            "lastpage": "451",
            "pmid": "28375029",
            "pub_year": 2017,
            "title": "Emerging experience with meningococcal serogroup B protein vaccines",
            "volume": "16"
        },
        "b0180": {
            "authors": [
                {
                    "first": "Ariane C.",
                    "initial": "A.C.",
                    "last": "Gomes"
                },
                {
                    "first": "Mona",
                    "initial": "M.",
                    "last": "Mohsen"
                },
                {
                    "first": "Martin F.",
                    "initial": "M.F.",
                    "last": "Bachmann"
                }
            ],
            "doi": "10.3390/vaccines5010006",
            "issn": "2076393X",
            "pub_year": 2017,
            "title": "Harnessing nanoparticles for immunomodulation and vaccines",
            "volume": "5"
        },
        "b0185": {
            "authors": [
                {
                    "first": "Helen",
                    "initial": "H.",
                    "last": "Petousis-Harris"
                },
                {
                    "first": "Janine",
                    "initial": "J.",
                    "last": "Paynter"
                },
                {
                    "first": "Jane",
                    "initial": "J.",
                    "last": "Morgan"
                },
                {
                    "first": "Peter",
                    "initial": "P.",
                    "last": "Saxton"
                },
                {
                    "first": "Barbara",
                    "initial": "B.",
                    "last": "McArdle"
                },
                {
                    "first": "Felicity",
                    "initial": "F.",
                    "last": "Goodyear-Smith"
                },
                {
                    "first": "Steven",
                    "initial": "S.",
                    "last": "Black"
                }
            ],
            "doi": "10.1016/S0140-6736(17)31449-6",
            "firstpage": "1603",
            "issn": "01406736",
            "lastpage": "1610",
            "pmid": "28705462",
            "pub_year": 2017,
            "title": "Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhoea in New Zealand: a retrospective case-control study",
            "volume": "390"
        },
        "b0190": {
            "authors": [
                {
                    "first": "Yehou M.D.",
                    "initial": "Y.M.D.",
                    "last": "Gnopo"
                },
                {
                    "first": "Hannah C.",
                    "initial": "H.C.",
                    "last": "Watkins"
                },
                {
                    "first": "Taylor C.",
                    "initial": "T.C.",
                    "last": "Stevenson"
                },
                {
                    "first": "Matthew P.",
                    "initial": "M.P.",
                    "last": "DeLisa"
                },
                {
                    "first": "David",
                    "initial": "D.",
                    "last": "Putnam"
                }
            ],
            "doi": "10.1016/j.addr.2017.05.003",
            "firstpage": "132",
            "issn": "0169409X",
            "lastpage": "142",
            "pmid": "28501509",
            "pub_year": 2017,
            "title": "Designer outer membrane vesicles as immunomodulatory systems \u2013 Reprogramming bacteria for vaccine delivery",
            "volume": "114"
        }
    },
    "body_text": [
        {
            "endOffset": 35647,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "secId": "s0060",
            "sentence": "To prepare human complement (HC) source, 2.5 ml of fresh normal HS with the addition of 50 \u00b5l of 0.5 M EDTA, pH 8 and 350 \u00b5l of 5 M NaCl was incubated first with anti-human IgM resin and then with Protein A/G Plus resin (with rotation) at 4 \u00b0C for 1 h each.",
            "startOffset": 35390,
            "title": "Complement-activated killing of Neisseriae"
        },
        {
            "endOffset": 31940,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Escherichia coli DH5\u03b1 (cloning) and BL21(DE3) pLysS strains (protein expression) were grown at 37 \u00b0C on Luria-Bertani (LB) agar, LB or SOB broths.",
            "startOffset": 31794,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 34799,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "secId": "s0045",
            "sentence": "Individual murine antisera were reacted with M2 rT-Nm-MIP, MC58, MC58\u0394mip, MC58\u0394mip::t- nm-mip, N. gonorrhoeae P9-17 and FA1090 OM preparations.",
            "startOffset": 34655,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 51501,
            "parents": [],
            "refoffsets": {
                "b0190": {
                    "endOffset": 51500,
                    "startOffset": 51496
                }
            },
            "secId": "s0100",
            "sentence": "Thus, future studies to engineer the OM to contain T-Nm-MIP should avoid the use of detergents and consider other genetic approaches to detoxify native LOS [38].",
            "startOffset": 51340,
            "title": "Discussion"
        },
        {
            "endOffset": 46666,
            "parents": [],
            "secId": "s0100",
            "sentence": "However, the HC-SBA assays used in the current study demonstrated that the bactericidal responses and the levels of cross-protection determined with the previous BRC-SBA were over-estimates.",
            "startOffset": 46476,
            "title": "Discussion"
        },
        {
            "endOffset": 43207,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "For MenC, rT-Nm-MIP-liposomes + MPLA antisera were bactericidal with a titre of 16; for MenW, rT-Nm-MIP-liposomes and rT-Nm-MIP-liposomes + MPLA antisera showed bactericidal titres of 8\u201316.",
            "startOffset": 43018,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 36554,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "The database contains 10,434 meningococcal and 3876 gonococcal isolates (accessed Jan. 2018) with 168 and 33 alleles identified, respectively.",
            "startOffset": 36412,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 48455,
            "parents": [],
            "secId": "s0100",
            "sentence": "We examined also the differences in amino acid sequences in the gonococcal MIP protein types, compared to meningococcal M2.",
            "startOffset": 48332,
            "title": "Discussion"
        },
        {
            "endOffset": 42658,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "By contrast, no killing was observed for any of the three MenB strains expressing M6 Nm-MIP protein.",
            "startOffset": 42558,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 47239,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 47238,
                    "startOffset": 47231
                },
                "b0105": {
                    "endOffset": 47238,
                    "startOffset": 47231
                },
                "b0110": {
                    "endOffset": 47238,
                    "startOffset": 47231
                }
            },
            "secId": "s0100",
            "sentence": "The lower bactericidal responses observed with the HC-SBA are consistent with the use of the more stringent complement source [20\u201322].",
            "startOffset": 47105,
            "title": "Discussion"
        },
        {
            "endOffset": 27771,
            "parents": [],
            "refoffsets": {
                "b0050": {
                    "endOffset": 27770,
                    "startOffset": 27763
                },
                "b0055": {
                    "endOffset": 27770,
                    "startOffset": 27763
                }
            },
            "secId": "s0005",
            "sentence": "Thus, new vaccine technologies have led to renewed interest in developing prophylactic gonococcal vaccines [10,11].",
            "startOffset": 27656,
            "title": "Introduction"
        },
        {
            "endOffset": 47806,
            "parents": [],
            "secId": "s0100",
            "sentence": "However, these are also the only two changes in N-terminal M1 protein, and meningococci expressing this type were killed, suggesting that these changes did not influence bactericidal activity with the M7-expressing strain.",
            "startOffset": 47584,
            "title": "Discussion"
        },
        {
            "endOffset": 48332,
            "parents": [],
            "secId": "s0100",
            "sentence": "Therefore, it is possible that the Ala140 and Asp142 residues are important for inducing bactericidal antibodies.",
            "startOffset": 48219,
            "title": "Discussion"
        },
        {
            "endOffset": 26880,
            "parents": [],
            "refoffsets": {
                "b0005": {
                    "endOffset": 26780,
                    "startOffset": 26777
                },
                "b0010": {
                    "endOffset": 26879,
                    "startOffset": 26876
                }
            },
            "secId": "s0005",
            "sentence": "Neisseria meningitidis (Nm, Men, meningococcus) is a major causative organism of meningitis and sepsis contributing significantly to mortality and morbidity worldwide [1], and Neisseria gonorrhoeae (Ng, gonococcus) causes the sexually transmitted disease gonorrhoea [2].",
            "startOffset": 26610,
            "title": "Introduction"
        },
        {
            "endOffset": 29449,
            "parents": [],
            "secId": "s0005",
            "sentence": "Ng-MIP is also highly conserved across all reported strains of N. gonorrhoeae, although the vaccine potential has not been reported.",
            "startOffset": 29317,
            "title": "Introduction"
        },
        {
            "endOffset": 28426,
            "parents": [],
            "refoffsets": {
                "b0060": {
                    "endOffset": 28425,
                    "startOffset": 28418
                },
                "b0065": {
                    "endOffset": 28425,
                    "startOffset": 28418
                }
            },
            "secId": "s0005",
            "sentence": "A possible candidate for inclusion in new vaccines is the Macrophage Infectivity Potentiator protein (MIP, NMB1567/NEIS1487), which is a member of the FK506-binding protein (FKBP)-type peptidyl prolyl cis/trans isomerase (PPIase) family of proteins [12,13].",
            "startOffset": 28169,
            "title": "Introduction"
        },
        {
            "endOffset": 36168,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0065",
            "sentence": "Data were compared using one-sample, two-sample or paired t-Tests, as appropriate, with P values < 0.05 considered significant.",
            "startOffset": 36041,
            "title": "Statistics"
        },
        {
            "endOffset": 44556,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "A MC58 \u0394mip strain was designed to over-express constitutively M2 T-Nm-MIP protein under the transcriptional control of a hybrid, strong PorA/NadA promoter, and lipooligosaccharide (LOS)-reduced OM then produced.",
            "startOffset": 44344,
            "title": "Expression of a truncated-Nm-MIP protein in the meningococcal OM"
        },
        {
            "endOffset": 28846,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 28845,
                    "startOffset": 28835
                },
                "b0080": {
                    "endOffset": 28845,
                    "startOffset": 28835
                },
                "b0085": {
                    "endOffset": 28845,
                    "startOffset": 28835
                }
            },
            "secId": "s0005",
            "sentence": "Nm-MIP is highly conserved and expressed by all meningococcal strains reported to date, is outer membrane (OM)-located, surface exposed and capable of inducing cross-protective bactericidal antibodies [13,16,17].",
            "startOffset": 28634,
            "title": "Introduction"
        },
        {
            "endOffset": 27342,
            "parents": [],
            "refoffsets": {
                "b0035": {
                    "endOffset": 27341,
                    "startOffset": 27338
                }
            },
            "secId": "s0005",
            "sentence": "Bexsero has shown a vaccine efficacy of 83% against all MenB cases in vaccine-eligible infants in the UK since 2015, equivalent to \u223c94% efficacy against the 88% predicted vaccine-preventable MenB strains [7].",
            "startOffset": 27134,
            "title": "Introduction"
        },
        {
            "endOffset": 41052,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "These antisera showed cross-reactivity with gonococci, specifically recognising a single band of Mr \u223c 29 kDa on western blots of P9-17 (Fig. 3D) and FA1090 (Fig. 3F) lysates.",
            "startOffset": 40878,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 43891,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Using HS-SBA, antisera to M2 rT-Nm-MIP-liposomes and M2 rT-Nm-MIP-liposomes + MPLA also showed significant bactericidal activity against gonococcal strain P9-17 that expressed M35 protein, with titres of 64\u2013128 and 64\u2013512, respectively (Table 2).",
            "startOffset": 43645,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 35785,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "secId": "s0060",
            "sentence": "The final HC eluate was dialyzed twice against filter-sterilized ice-cold TBS, 0.1 mM EDTA and brought back to 2.5 ml in the same buffer.",
            "startOffset": 35648,
            "title": "Complement-activated killing of Neisseriae"
        },
        {
            "endOffset": 42221,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Using the HC-SBA, murine antisera raised to M2 rT-Nm-MIP were bactericidal for the homologous strains MC58 and MC168 with median titres of 32\u201364 for the rT-Nm-MIP-liposome preparations and 128\u2013256 for the rT-Nm-MIP-liposome + MPLA preparations (Table 2).",
            "startOffset": 41967,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 44343,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "An alternative strategy for presentation of truncated Nm-MIP protein was attempted.",
            "startOffset": 44260,
            "title": "Expression of a truncated-Nm-MIP protein in the meningococcal OM"
        },
        {
            "endOffset": 37066,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 36966,
                    "startOffset": 36962
                }
            },
            "secId": "s0075",
            "sentence": "The percentage distribution of meningococcal isolates amongst the non-redundant alleles has not changed significantly since a previous analysis [13], with the majority expressing protein encoded by Allele 2 (41%), Allele 1 (32%) and Allele 7 (11%).",
            "startOffset": 36818,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 44975,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "Instead, LOS was extracted from wild-type MC58, MC58\u0394mip and MC58\u0394mip::t-nm-mip bacteria with Na-DOC, and mice were immunized with all three native OM and Na-DOC OM preparations (Supplementary Fig. 5).",
            "startOffset": 44774,
            "title": "Expression of a truncated-Nm-MIP protein in the meningococcal OM"
        },
        {
            "endOffset": 38144,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "We now re-assign the MIP Type designation by referring to the representative allele encoding for a particular non-redundant MIP protein, thus becoming independent of the isolate frequency ranking for each particular MIP type, which varies as the database grows in number of isolates reported.",
            "startOffset": 37852,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 46832,
            "parents": [],
            "secId": "s0100",
            "sentence": "Thus, no cross-protective bactericidal activity was observed against M6-expressing strains, or against MenA or MenY bacteria expressing homologous M2 Nm-MIP protein.",
            "startOffset": 46667,
            "title": "Discussion"
        },
        {
            "endOffset": 50882,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 50839,
                    "startOffset": 50835
                }
            },
            "secId": "s0100",
            "sentence": "This important observation suggests that meningococcal and gonococcal OM probably share common antigens, including MIP [13], which may contribute to cross-protection.",
            "startOffset": 50716,
            "title": "Discussion"
        },
        {
            "endOffset": 38975,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Within the C-terminal truncated region, homology between the gonococcal sequences and M2 was 98\u201399% and marginally more variability between the different meningococcal sequences (96\u201399%) (Supplementary Fig. 4).",
            "startOffset": 38765,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 41639,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Flow cytometry demonstrated that antisera to rT-Nm-MIP-liposomes and rT-Nm-MIP-liposome + MPLA preparations reacted with live wild-type MC58 (Nm-MIP+) and complemented (Truncated-Nm-MIP+) bacteria, showing significant (P < 0.05) right-shifted increases in FITC-fluorescence recorded events, compared to sham-immunised murine sera (Fig. 4).",
            "startOffset": 41300,
            "title": "Antibodies to rT-Nm-MIP recognize MIP protein expressed on the surface of live meningococci and gonococci"
        },
        {
            "endOffset": 42860,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Of the two MenB strains that expressed M7 protein tested, one (M16 240169) was killed by antisera to rT-Nm-MIP-lipsomes + MPLA at low levels (titres 4\u20138), whereas the other (M15 240139) was not killed.",
            "startOffset": 42659,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 28633,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 28518,
                    "startOffset": 28511
                },
                "b0070": {
                    "endOffset": 28518,
                    "startOffset": 28511
                },
                "b0075": {
                    "endOffset": 28632,
                    "startOffset": 28628
                }
            },
            "secId": "s0005",
            "sentence": "Expression of the nm-mip gene was important for meningococcal survival in the blood [13,14] and inhibition of Nm-MIP prevented meningococci from adhering, invading and/or surviving in epithelial cells [15].",
            "startOffset": 28427,
            "title": "Introduction"
        },
        {
            "endOffset": 36028,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "refoffsets": {
                "b0110": {
                    "endOffset": 35946,
                    "startOffset": 35939
                },
                "b0145": {
                    "endOffset": 35892,
                    "startOffset": 35888
                },
                "b0150": {
                    "endOffset": 35946,
                    "startOffset": 35939
                },
                "b0155": {
                    "endOffset": 36027,
                    "startOffset": 36023
                }
            },
            "secId": "s0060",
            "sentence": "The bactericidal activity of pooled murine anti-rT-Nm-MIP sera was determined as described previously [29], using 25% (v/v) HC for meningococcal strains [22,30] and 17% (v/v) HS as a source of exogenous complement for gonococcal strains [31].",
            "startOffset": 35786,
            "title": "Complement-activated killing of Neisseriae"
        },
        {
            "endOffset": 40392,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "No significant reactivity (P > 0.05) was observed for any antiserum against MC58\u0394mip, P9-17\u0394mip or FA1090\u0394mip OM preparations (data not shown).",
            "startOffset": 40249,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 43483,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "It is possible that variation in surface expression of M2 protein accounted for the differences in bactericidal activity observed between these different serogroup meningococci.",
            "startOffset": 43306,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 51652,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 51651,
                    "startOffset": 51647
                },
                "b0075": {
                    "endOffset": 51597,
                    "startOffset": 51593
                }
            },
            "secId": "s0105",
            "sentence": "Neisseria MIP proteins are potential targets for drug therapies during infection [15] and for the development of prophylactic vaccines [13].",
            "startOffset": 51512,
            "title": "Conclusion"
        },
        {
            "endOffset": 28000,
            "parents": [],
            "secId": "s0005",
            "sentence": "The impact of new MenB vaccines on the levels of protection, the epidemiology of circulating meningococcal strains, the potential for selection of new antigenic variants and variation in protein expression, needs to be monitored.",
            "startOffset": 27771,
            "title": "Introduction"
        },
        {
            "endOffset": 34457,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "The study was approved by the Animal Welfare and Ethics Review Board at the authors\u2019 institution (no number assigned).",
            "startOffset": 34339,
            "title": "Animal immunizations"
        },
        {
            "endOffset": 36817,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Analysis of the translated proteins encoded by the nucleotide sequences of these different alleles identified 75 and 18 non-redundant NEIS1487 amino acid sequences amongst meningococci and gonococci respectively (Supplementary Table 2; Supplementary Figs. 2, 3).",
            "startOffset": 36555,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 31525,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0115": {
                    "endOffset": 31524,
                    "startOffset": 31520
                }
            },
            "secId": "s0015",
            "sentence": "Wild type and mutant strains were grown on supplemented GC agar plates, incubated at 37 \u00b0C, 5% (v/v) CO2 [23].",
            "startOffset": 31415,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 41886,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Specificity was confirmed by the lack of reactivity (P > 0.05) of all murine post-immune sera with MC58\u0394mip, P9-17\u0394mip or FA1090\u0394mip strains (Fig. 4).",
            "startOffset": 41736,
            "title": "Antibodies to rT-Nm-MIP recognize MIP protein expressed on the surface of live meningococci and gonococci"
        },
        {
            "endOffset": 30686,
            "parents": [],
            "secId": "s0005",
            "sentence": "For examining bactericidal activity of antisera raised to recombinant proteins, it is preferable that MenB and gonococcal SBAs use a human complement/human serum (HC/HS) source rather than BRC, which tends to inflate bactericidal titres due to the presence of IgM antibodies.",
            "startOffset": 30411,
            "title": "Introduction"
        },
        {
            "endOffset": 37239,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "For gonococci, most isolates expressed protein encoded by Allele 10 (59%) or Allele 35 (27%) and fewer isolates by other alleles e.g. Allele 8 (5%) (Supplementary Table 2).",
            "startOffset": 37067,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 32881,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0135": {
                    "endOffset": 32799,
                    "startOffset": 32795
                }
            },
            "secId": "s0025",
            "sentence": "For chromosomal complementation of MC58\u0394mip strain, the 3\u2032-end truncated nm-mip gene (encoding for AA1-143) under transcriptional regulation of a strong and constitutive PorA/NadA hybrid promoter [27] was engineered in silico into pMA-T (GeneArt) and subsequently cloned into pGCC5.",
            "startOffset": 32599,
            "title": "Complementation of MC58\u0394nm-mip strain with c-term truncated nm-mip"
        },
        {
            "endOffset": 47394,
            "parents": [],
            "secId": "s0100",
            "sentence": "Although the N-terminal region of MIP is well-conserved, we examined whether the specific amino acid residue differences influenced bactericidal activity.",
            "startOffset": 47240,
            "title": "Discussion"
        },
        {
            "endOffset": 47105,
            "parents": [],
            "secId": "s0100",
            "sentence": "For the gonococcal strains tested, bactericidal activity was observed for P9-17 (M35 Ng-MIP) and one strain 12CFX_T_003 (M10 Ng-MIP) but not for a strain expressing M8 Ng-MIP.",
            "startOffset": 46930,
            "title": "Discussion"
        },
        {
            "endOffset": 33662,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "Mature M2 (Type I) rT-Nm-MIP protein (13.93 kDa) was purified by Ni-NTA affinity chromatography under native conditions (Supplementary Fig. 1).",
            "startOffset": 33519,
            "title": "Cloning, expression, and purification of recombinant full and T-Nm-MIP (M2, Type I) proteins"
        },
        {
            "endOffset": 30223,
            "parents": [],
            "secId": "s0005",
            "sentence": "A baby rabbit complement Serum Bactericidal Assay (BRC-SBA) demonstrated that antibodies to rT-Nm-MIP Type I protein were bactericidal for MenB bacteria expressing different MIP (Type I, II and III) proteins and for MenA, MenC, MenW and MenY bacteria expressing the same MIP protein.",
            "startOffset": 29940,
            "title": "Introduction"
        },
        {
            "endOffset": 35150,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 35149,
                    "startOffset": 35142
                },
                "b0085": {
                    "endOffset": 35149,
                    "startOffset": 35142
                }
            },
            "secId": "s0050",
            "sentence": "Immunological reactivity of murine sera to OM preparations was detected with anti-mouse/rabbit immunoglobulin-alkaline phosphatase conjugates, as described previously [16,17].",
            "startOffset": 34975,
            "title": "SDS-PAGE and western immunoblotting"
        },
        {
            "endOffset": 49434,
            "parents": [],
            "secId": "s0100",
            "sentence": "Unexpectedly, there was variation in bactericidal activity of antisera to M2 rT-Nm-MIP tested against M2-expressing meningococci of different serogroups.",
            "startOffset": 49281,
            "title": "Discussion"
        },
        {
            "endOffset": 51085,
            "parents": [],
            "secId": "s0100",
            "sentence": "Therefore, engineering Nm-OMV vaccine(s) to express MIP and other proteins that cover the majority of meningococci and gonococci circulating in the populations, is a strategy that could be investigated.",
            "startOffset": 50883,
            "title": "Discussion"
        },
        {
            "endOffset": 34040,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34039,
                    "startOffset": 34035
                }
            },
            "secId": "s0035",
            "sentence": "Groups of five BALB/c mice (H-2d haplotype) were immunized intraperitoneally with purified M2 rT-Nm-MIP protein delivered in liposomes, with or without Monophosphoryl Lipid A (MPLA), or with OM and Na-DOC OM preparations from strains MC58, MC58\u0394mip and MC58\u0394mip::t-nm-mip adsorbed to Al(OH)3, following the immunization schedule described previously [16].",
            "startOffset": 33685,
            "title": "Animal immunizations"
        },
        {
            "endOffset": 48670,
            "parents": [],
            "secId": "s0100",
            "sentence": "The N-terminal domains of both proteins were identical with the only three changes being Ser39Ala, Ser49Gly and Glu83Asp (Fig. 4).",
            "startOffset": 48540,
            "title": "Discussion"
        },
        {
            "endOffset": 29939,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 29938,
                    "startOffset": 29934
                }
            },
            "secId": "s0005",
            "sentence": "Molecular mimicry between Nm-MIP with hFKBP2 protein was obviated by generating a recombinant truncated protein (rT-Nm-MIP, AA22-143), which induced murine bactericidal antibodies against meningococci that did not recognise human FKBP protein [16].",
            "startOffset": 29691,
            "title": "Introduction"
        },
        {
            "endOffset": 43995,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Specificity was shown by the inability of any antisera to kill the isogenic P9-17\u0394mip strain (Table 2).",
            "startOffset": 43892,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 41735,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0085",
            "sentence": "Antisera cross-reacted similarly with Ng-MIP on the surface of live P9-17 and FA1090 gonococci.",
            "startOffset": 41640,
            "title": "Antibodies to rT-Nm-MIP recognize MIP protein expressed on the surface of live meningococci and gonococci"
        },
        {
            "endOffset": 51222,
            "parents": [],
            "secId": "s0100",
            "sentence": "In the current study, we were able to engineer successfully the Nm-OM to express M2 Truncated \u2013Nm-MIP constitutively and at high levels.",
            "startOffset": 51086,
            "title": "Discussion"
        },
        {
            "endOffset": 46147,
            "parents": [],
            "secId": "s0100",
            "sentence": "The major findings from the current study were: (1) different batches of rT-Nm-MIP protein in liposomes and liposomes + MPLA showed no significant batch-to-batch variation in antigenicity; (2) the antibodies induced reacted specifically with Nm-MIP and Ng-MIP in their OM preparations and bound equally and specifically to live meningococcal and gonococcal cell surfaces; (3) use of HC/HS-SBA demonstrated that antisera to rT-Nm-MIP preparations killed meningococci and were cross-protective against gonococci, but there was significant divergence in bactericidal responses between different strains; (4) meningococcal OM were engineered to express T\u2013Nm-MIP constitutively and at high levels as an alternative to recombinant protein production, but the use of Na-DOC for LOS extraction was contra-indicated.",
            "startOffset": 45340,
            "title": "Discussion"
        },
        {
            "endOffset": 34338,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "This study complied with the animal experimentation guidelines of the Home Office (HO), with approval granted under the Animals Scientific Procedures Act, 1986 (HO PPL 3003126).",
            "startOffset": 34161,
            "title": "Animal immunizations"
        },
        {
            "endOffset": 41192,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Specificity was confirmed by the lack of reactivity of any of the antisera with P9-17\u0394mip (Fig. 3E) or FA1090\u0394mip (Fig. 3G) mutant strains.",
            "startOffset": 41053,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 50715,
            "parents": [],
            "refoffsets": {
                "b0185": {
                    "endOffset": 50714,
                    "startOffset": 50710
                }
            },
            "secId": "s0100",
            "sentence": "A recent epidemiological study suggested that vaccination with the MeNZB OMV vaccine in New Zealand was associated with statistically significant reduction in the rates of gonorrhoea diagnosis, with an estimated effectiveness of the vaccine against gonorrhoea of 31% [37].",
            "startOffset": 50443,
            "title": "Discussion"
        },
        {
            "endOffset": 47989,
            "parents": [],
            "secId": "s0100",
            "sentence": "By contrast, Asp123 residue, which is conserved in all of the protein types, is changed to a Glu only in the M7 type protein and therefore may be important for bactericidal activity.",
            "startOffset": 47807,
            "title": "Discussion"
        },
        {
            "endOffset": 46929,
            "parents": [],
            "secId": "s0100",
            "sentence": "Against strains expressing M7 (Type IV) protein, the bactericidal activity levels were marginal.",
            "startOffset": 46833,
            "title": "Discussion"
        },
        {
            "endOffset": 51897,
            "parents": [],
            "secId": "s0105",
            "sentence": "Our data demonstrate the reproducibility of independent vaccines batches for generating bactericidal antibodies against a panel of homologous and heterologous MIP Type and serogroup meningococci, and cross-reactive with some gonococcal strains.",
            "startOffset": 51653,
            "title": "Conclusion"
        },
        {
            "endOffset": 43645,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "However, FACS analyses showed no significant differences (P > 0.05) of surface expression of M2 protein in the MenA, MenB, MenC, MenW and MenY isolates (Fig. 5).",
            "startOffset": 43484,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 29585,
            "parents": [],
            "secId": "s0005",
            "sentence": "Recently, we reported that Nm-MIP and human FKBP2 PPIase protein shared \u223c48% similarity of amino acids (AA) located in region AA166-252.",
            "startOffset": 29449,
            "title": "Introduction"
        },
        {
            "endOffset": 34935,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 34934,
                    "startOffset": 34927
                },
                "b0085": {
                    "endOffset": 34934,
                    "startOffset": 34927
                }
            },
            "secId": "s0045",
            "sentence": "Immunological reactivity was detected with anti-mouse immunoglobulin-horseradish peroxidase conjugate, as described previously [16,17].",
            "startOffset": 34800,
            "title": "Enzyme-linked immunosorbent assay (ELISA)"
        },
        {
            "endOffset": 33260,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 33259,
                    "startOffset": 33255
                }
            },
            "secId": "s0030",
            "sentence": "Cloning, expression and purification of full-length rNm-MIP (M2, Type I) protein was described previously [17].",
            "startOffset": 33149,
            "title": "Cloning, expression, and purification of recombinant full and T-Nm-MIP (M2, Type I) proteins"
        },
        {
            "endOffset": 30410,
            "parents": [],
            "secId": "s0005",
            "sentence": "Antisera to rT-Nm-MIP appeared also to show bactericidal activity against a gonococcal strain P9-17, although the BRC-SBA showed high levels of background killing by sham-immunized sera.",
            "startOffset": 30224,
            "title": "Introduction"
        },
        {
            "endOffset": 34587,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "Animal health and welfare was assessed daily by qualified animal technicians and no animals suffered significant adverse effects.",
            "startOffset": 34458,
            "title": "Animal immunizations"
        },
        {
            "endOffset": 31414,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0015",
            "sentence": "Bacteria used in this study are listed in Table 1.",
            "startOffset": 31364,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 42317,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Specificity was demonstrated by the inability of antisera to kill the isogenic MC58\u0394mip strain.",
            "startOffset": 42222,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 34161,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0035",
            "sentence": "All sera were stored at -20 \u00b0C until required and decomplemented by heating at 56 \u00b0C for 30 min before use in HC/HS-SBA.",
            "startOffset": 34041,
            "title": "Animal immunizations"
        },
        {
            "endOffset": 35343,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                },
                {
                    "id": "s0040",
                    "title": "Antibody properties"
                }
            ],
            "refoffsets": {
                "b0080": {
                    "endOffset": 35342,
                    "startOffset": 35335
                },
                "b0085": {
                    "endOffset": 35342,
                    "startOffset": 35335
                }
            },
            "secId": "s0055",
            "sentence": "Binding of antibodies to MC58, MC58\u0394mip, MC58\u0394mip::t-nm-mip, P9-17, P9-17\u0394mip, FA1090 and FA1090\u0394mip bacteria was examined by flow cytometry, as described previously [16,17].",
            "startOffset": 35169,
            "title": "Flow cytometry"
        },
        {
            "endOffset": 32402,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0070": {
                    "endOffset": 32355,
                    "startOffset": 32348
                },
                "b0080": {
                    "endOffset": 32355,
                    "startOffset": 32348
                }
            },
            "secId": "s0020",
            "sentence": "Construction of MC58\u0394mip, FA1090\u0394mip and P9-17\u0394mip mutant strains was done as described previously [14,16] using primers listed in Supplementary Table 1.",
            "startOffset": 32249,
            "title": "Construction of Neisseria meningitidis nm-mip gene and Neisseria gonorrhoeae ng-mip gene knock-out mutants"
        },
        {
            "endOffset": 36411,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0160": {
                    "endOffset": 36358,
                    "startOffset": 36354
                }
            },
            "secId": "s0075",
            "sentence": "The DNA sequences of the nmb1567/neis1487 gene from pathogenic Neisseria strains in the pubmlst.org/Neisseria database [32] were translated to amino acid sequences and aligned.",
            "startOffset": 36235,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 50443,
            "parents": [],
            "refoffsets": {
                "b0175": {
                    "endOffset": 50360,
                    "startOffset": 50356
                },
                "b0180": {
                    "endOffset": 50398,
                    "startOffset": 50394
                }
            },
            "secId": "s0100",
            "sentence": "These would include testing a broader range of adjuvants and using methods to increase antigen density, e.g. by generating fusion proteins, in a manner described with Bexsero antigens [35] or by using virus-like particles [36] to present multiple truncated MIP sequences.",
            "startOffset": 50172,
            "title": "Discussion"
        },
        {
            "endOffset": 27455,
            "parents": [],
            "refoffsets": {
                "b0040": {
                    "endOffset": 27454,
                    "startOffset": 27451
                }
            },
            "secId": "s0005",
            "sentence": "A 50% reduction in MenB cases was observed in the vaccine eligible age-group, which seems to have persisted [8].",
            "startOffset": 27343,
            "title": "Introduction"
        },
        {
            "endOffset": 39413,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The batch consistency of M2 rT-Nm-MIP-liposome (n = 3) and M2 rT-Nm-MIP-liposome + MPLA (n = 3) vaccines was assessed initially by testing individual antisera in ELISA against the immunizing protein, homologous MC58 OM, and OM from a MC58 mip knock-out strain that was engineered to constitutively express the mip gene fragment encoding the truncated protein without the 6 \u00d7 HIS tag (AA22-143).",
            "startOffset": 39019,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 39689,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "High titres of antibodies, reactive with homologous immunizing protein, were induced by rT-Nm-MIP in all six liposomal preparations (Fig. 2A), and no significant differences between the mean antibody titres was observed (mean \u223c2.6 \u00d7 106, range 0.6 \u00d7 106\u20131.2 \u00d7 107, P > 0.05).",
            "startOffset": 39414,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 29690,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 29689,
                    "startOffset": 29685
                }
            },
            "secId": "s0005",
            "sentence": "The C-terminal globular domain of Nm-MIP covers AA143-272 and contains the PPIase FKBP-type domain [16].",
            "startOffset": 29586,
            "title": "Introduction"
        },
        {
            "endOffset": 42557,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Antisera to M2 rT-Nm-MIP also induced complement-mediated killing of MenB strains expressing heterologous M1 protein, with bactericidal titres of 64 with rT-Nm-MIP-liposome preparations and 128\u2013256 with rT-Nm-MIP-liposome + MPLA (Table 2).",
            "startOffset": 42318,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 51339,
            "parents": [],
            "secId": "s0100",
            "sentence": "However, LOS-extraction with Na-DOC was contra-indicated, as it led to loss of the majority of T-Nm-MIP from the OM.",
            "startOffset": 51223,
            "title": "Discussion"
        },
        {
            "endOffset": 48051,
            "parents": [],
            "secId": "s0100",
            "sentence": "Meningococci expressing M6 protein type were also not killed.",
            "startOffset": 47990,
            "title": "Discussion"
        },
        {
            "endOffset": 32057,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0125": {
                    "endOffset": 32056,
                    "startOffset": 32049
                },
                "b0130": {
                    "endOffset": 32056,
                    "startOffset": 32049
                }
            },
            "secId": "s0015",
            "sentence": "OM of MC58, MC58\u0394mip and MC58\u0394mip::t-nm-mip, P9-17 and FA1090 bacteria were prepared as described previously [25,26].",
            "startOffset": 31940,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 32941,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0140": {
                    "endOffset": 32940,
                    "startOffset": 32936
                }
            },
            "secId": "s0025",
            "sentence": "This construct was used to complement MC58\u0394mip strain [28].",
            "startOffset": 32882,
            "title": "Complementation of MC58\u0394nm-mip strain with c-term truncated nm-mip"
        },
        {
            "endOffset": 27655,
            "parents": [],
            "refoffsets": {
                "b0045": {
                    "endOffset": 27654,
                    "startOffset": 27651
                }
            },
            "secId": "s0005",
            "sentence": "By contrast, there are no gonorrhoea vaccines and infection control has relied on antibiotics, but this is being severely compromised by the emergence of antibiotic-resistant gonococci worldwide [9].",
            "startOffset": 27456,
            "title": "Introduction"
        },
        {
            "endOffset": 37851,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 37850,
                    "startOffset": 37843
                },
                "b0085": {
                    "endOffset": 37850,
                    "startOffset": 37843
                }
            },
            "secId": "s0075",
            "sentence": "The MIP Type designation scheme was originally based on the isolate frequency for each non-redundant protein, referred to as Types I-IV, with Type I being the most abundant Type protein within all N. meningitidis isolates reported [13,17].",
            "startOffset": 37612,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 38547,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0065": {
                    "endOffset": 38429,
                    "startOffset": 38425
                }
            },
            "secId": "s0075",
            "sentence": "Thus, in meningococci, M (i.e. MIP)2 protein is encoded by Allele 2 (formerly Nm-MIP Type I), M1 protein is encoded by Allele 1 (formerly Nm-MIP Type II), M6 protein is encoded by Allele 6 (formerly Nm-MIP Type III) and M7 protein is encoded by Allele 7 (formerly Nm-MIP Type IV) [13] and in gonococci, M8, M10 and M35 proteins are encoded by Alleles 8, 10 and 35, respectively (Supplementary Table 2).",
            "startOffset": 38145,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 38764,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Alignment of the amino acid sequences of the most prevalent meningococcal (M1, 2, 6, 7) and gonococcal (M8, 10, 35) allele-encoded proteins showed a high degree of homology between the whole proteins (97\u201399%, Fig. 1).",
            "startOffset": 38547,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 44193,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "No killing was observed for strain FA1090, which expressed the M8 protein (Table 2).",
            "startOffset": 44109,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 49145,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 49032,
                    "startOffset": 49028
                }
            },
            "secId": "s0100",
            "sentence": "It is possible that PorinB-mediated serum resistance imparted by binding of complement proteins and factor H [34] prevented the bactericidal activity of M2 rT-Nm-MIP antiserum, instead of these amino acid sequence differences.",
            "startOffset": 48919,
            "title": "Discussion"
        },
        {
            "endOffset": 49281,
            "parents": [],
            "secId": "s0100",
            "sentence": "However, a limitation of the current study is that significantly larger numbers of isolates should be tested to confirm these findings.",
            "startOffset": 49146,
            "title": "Discussion"
        },
        {
            "endOffset": 48789,
            "parents": [],
            "secId": "s0100",
            "sentence": "Surprisingly, gonococci expressing M8 protein, which also has the Ser39Ala and Glu83Asp substitutions, was not killed.",
            "startOffset": 48671,
            "title": "Discussion"
        },
        {
            "endOffset": 40494,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "The specificity of the immune response against rT-Nm-MIP protein was demonstrated by western blotting.",
            "startOffset": 40392,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 44108,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "Murine antisera also killed one strain expressing M10 protein, 12CFX_T_003 (titres 8\u201316), but not another, MS11.",
            "startOffset": 43996,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 45329,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0095",
            "sentence": "However, western blotting (Supplementary Fig. 6) and mass spectrometry analysis (data not shown) of the native OM, Na-DOC OM and all corresponding washes throughout the extraction process, demonstrated high solubility of full-length mature and truncated Nm-MIP proteins in Na-DOC that resulted in a significant loss of target antigen from within the OM.",
            "startOffset": 44976,
            "title": "Expression of a truncated-Nm-MIP protein in the meningococcal OM"
        },
        {
            "endOffset": 28168,
            "parents": [],
            "secId": "s0005",
            "sentence": "Next-generation MenB vaccines may see the incorporation of additional antigens capable of inducing serum bactericidal antibodies, the accepted correlate of protection.",
            "startOffset": 28001,
            "title": "Introduction"
        },
        {
            "endOffset": 46475,
            "parents": [],
            "refoffsets": {
                "b0080": {
                    "endOffset": 46474,
                    "startOffset": 46470
                }
            },
            "secId": "s0100",
            "sentence": "Previously, we demonstrated using the BRC-SBA that antisera to M2 rT-Nm-MIP (Type I) protein were bactericidal against the (i) homologous MenB strain, (ii) heterologous MenB strains expressing M1 (Type II) and M6 (Type III) proteins and (iii) heterologous MenA, MenC, MenW and MenY bacteria expressing homologous M2 Nm-MIP [16].",
            "startOffset": 46147,
            "title": "Discussion"
        },
        {
            "endOffset": 37612,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0075",
            "sentence": "Only Allele 10 and 63 were found in both meningococci and gonococci (Supplementary Fig. 3), though only 5 gonococcal isolates expressed Allele 63-encoded protein compared to a total of 115 meningococcal isolates, and conversely only 2 meningococcal isolates (not determined) expressed Allele 10-encoded protein compared to 2274 gonococcal isolates (Supplementary Table 2).",
            "startOffset": 37240,
            "title": "Conservation of NEIS1487 in pathogenic Neisseria species"
        },
        {
            "endOffset": 31793,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0120": {
                    "endOffset": 31792,
                    "startOffset": 31788
                }
            },
            "secId": "s0015",
            "sentence": "For human complement-mediated serum bactericidal assays (HC-SBA), N. gonorrhoeae strains MS11 and 12CFX_T_003 were grown on supplemented GC agar plates with the addition of Cytidine-5\u2032-MonoPhospho-N-AcetylNeuraminic Acid to impart resistance to human serum (HS) [24].",
            "startOffset": 31526,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 33518,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "secId": "s0030",
            "sentence": "The 3\u2032-truncated nm-mip gene sequence, encoding the N-terminal amino acid sequence (AA 22\u2013143) for NMB1567 protein (NEIS1487, http://pubmlst.org/neisseria/, 819 bp), was amplified by PCR using primers listed in Supplementary Table 1, and ligated to pET24b+.",
            "startOffset": 33261,
            "title": "Cloning, expression, and purification of recombinant full and T-Nm-MIP (M2, Type I) proteins"
        },
        {
            "endOffset": 33054,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 33053,
                    "startOffset": 33049
                }
            },
            "secId": "s0025",
            "sentence": "Positive transformants were identified by PCR screening and western blotting with rabbit anti-rNm-MIP sera [17].",
            "startOffset": 32942,
            "title": "Complementation of MC58\u0394nm-mip strain with c-term truncated nm-mip"
        },
        {
            "endOffset": 32140,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0130": {
                    "endOffset": 32139,
                    "startOffset": 32135
                }
            },
            "secId": "s0015",
            "sentence": "Treatment with sodium deoxycholate (Na-DOC) was done as described previously [26].",
            "startOffset": 32058,
            "title": "Bacteria, growth conditions and preparation of outer membranes (OM)"
        },
        {
            "endOffset": 48918,
            "parents": [],
            "secId": "s0100",
            "sentence": "Taken together, these observations suggest that these three amino acid residues are not important for the bactericidal response.",
            "startOffset": 48790,
            "title": "Discussion"
        },
        {
            "endOffset": 40755,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Pooled antisera of the independent batches of rT-Nm-MIP-liposomes and rT-Nm-MIP-liposomes + MPLA vaccines showed strong and similar reactivity with a single band of molecular mass (Mr) \u223c29 kDa on MC58 OM (Fig. 3A) or \u223c14 kDa (Fig. 3C) on MC58\u0394mip::t-nm-mip OM.",
            "startOffset": 40495,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 32530,
            "parents": [
                {
                    "id": "s0010",
                    "title": "Materials and methods"
                }
            ],
            "refoffsets": {
                "b0085": {
                    "endOffset": 32529,
                    "startOffset": 32525
                }
            },
            "secId": "s0020",
            "sentence": "Transformed colonies were screened by PCR and confirmed by western blotting using cross-reacting rabbit anti-rNm-MIP sera [17].",
            "startOffset": 32403,
            "title": "Construction of Neisseria meningitidis nm-mip gene and Neisseria gonorrhoeae ng-mip gene knock-out mutants"
        },
        {
            "endOffset": 43305,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "By contrast, no significant bactericidal effect was observed for MenA or MenY bacteria (Table 2).",
            "startOffset": 43208,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 39923,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "These antibodies also reacted with homologous OM (Fig. 2B) and the engineered rT-Nm-MIP-OM (Fig. 2C), with similar titres observed (\u223c0.37\u20130.67 \u00d7 106, P > 0.05) with all the immunizing preparations tested against both OM preparations.",
            "startOffset": 39690,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 40248,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Notably, antisera to all the rT-Nm-MIP-liposome and rT-Nm-MIP-liposome + MPLA vaccines showed strong cross-reactivity with N. gonorrhoeae P9-17 (Fig. 2D) and FA1090 (Fig. 2E) OM preparations, with similar mean reciprocal titres (0.4\u20131.4 \u00d7 106), not significantly different (P > 0.05) from those observed on meningococcal OM.",
            "startOffset": 39924,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 50072,
            "parents": [],
            "secId": "s0100",
            "sentence": "The most effective vaccine formulation was rT-Nm-MIP- liposomes + MPLA, which increased bactericidal titres compared with rT-Nm-MIP-liposomes, albeit by only a factor of 2\u20134-fold.",
            "startOffset": 49893,
            "title": "Discussion"
        },
        {
            "endOffset": 40877,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0080",
            "sentence": "Specificity was confirmed by the lack of reactivity of any of the antisera with MC58\u0394mip mutant OM preparation (Fig. 3B).",
            "startOffset": 40756,
            "title": "Antigenicity of rT-Nm-MIP vaccine batches"
        },
        {
            "endOffset": 43017,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "secId": "s0090",
            "sentence": "For meningococci expressing homologous M2 protein but different serogroup capsule, significant killing was observed against MenC and MenW bacteria (Table 2).",
            "startOffset": 42860,
            "title": "Murine antibodies to rT-Nm-MIP are bactericidal for meningococci and gonococci"
        },
        {
            "endOffset": 50171,
            "parents": [],
            "secId": "s0100",
            "sentence": "Several strategies could be considered for improving the immune response to the truncated protein.",
            "startOffset": 50073,
            "title": "Discussion"
        },
        {
            "endOffset": 29117,
            "parents": [],
            "refoffsets": {
                "b0090": {
                    "endOffset": 29116,
                    "startOffset": 29109
                },
                "b0095": {
                    "endOffset": 29116,
                    "startOffset": 29109
                }
            },
            "secId": "s0005",
            "sentence": "N. gonorrhoeae also produces a FKBP-type PPIase and expression of the surface-exposed 30 kDa Ng-MIP lipoprotein appeared to be important for bacterial persistence within macrophages and protected gonococci from the bactericidal activity of immune effector cells [18,19].",
            "startOffset": 28847,
            "title": "Introduction"
        },
        {
            "endOffset": 48218,
            "parents": [],
            "secId": "s0100",
            "sentence": "In this protein, Ala140 and Asp142, which are conserved in the N-terminal domain of all of the other protein types, is changed to a Gly and Glu residue, respectively.",
            "startOffset": 48052,
            "title": "Discussion"
        },
        {
            "endOffset": 29316,
            "parents": [],
            "refoffsets": {
                "b0065": {
                    "endOffset": 29315,
                    "startOffset": 29305
                },
                "b0090": {
                    "endOffset": 29315,
                    "startOffset": 29305
                },
                "b0095": {
                    "endOffset": 29315,
                    "startOffset": 29305
                }
            },
            "secId": "s0005",
            "sentence": "Sera from patients with urethritis or disseminated gonococcal infections recognized purified Ng-MIP, suggesting that this antigen is expressed during infection in vivo and is immunogenic [13,18,19].",
            "startOffset": 29118,
            "title": "Introduction"
        },
        {
            "endOffset": 27133,
            "parents": [],
            "refoffsets": {
                "b0015": {
                    "endOffset": 27044,
                    "startOffset": 27039
                },
                "b0020": {
                    "endOffset": 27044,
                    "startOffset": 27039
                },
                "b0025": {
                    "endOffset": 27132,
                    "startOffset": 27127
                },
                "b0030": {
                    "endOffset": 27132,
                    "startOffset": 27127
                }
            },
            "secId": "s0005",
            "sentence": "Capsular polysaccharide-conjugate vaccines to prevent infections by MenA, MenC, MenW and MenY meningococci are widely available, routinely used and effective [3,4], and two new vaccines Bexsero and Trumenba, have been licensed for MenB infection [5,6].",
            "startOffset": 26881,
            "title": "Introduction"
        },
        {
            "endOffset": 30864,
            "parents": [],
            "refoffsets": {
                "b0100": {
                    "endOffset": 30863,
                    "startOffset": 30856
                },
                "b0105": {
                    "endOffset": 30863,
                    "startOffset": 30856
                },
                "b0110": {
                    "endOffset": 30863,
                    "startOffset": 30856
                }
            },
            "secId": "s0005",
            "sentence": "It has been reported also that the HC-SBA is conservative with a high rate of false-negatives, which makes the assay less sensitive, but more specific, that the BRC-SBA [20\u201322].",
            "startOffset": 30687,
            "title": "Introduction"
        },
        {
            "endOffset": 44773,
            "parents": [
                {
                    "id": "s0070",
                    "title": "Results"
                }
            ],
            "refoffsets": {
                "b0165": {
                    "endOffset": 44772,
                    "startOffset": 44768
                }
            },
            "secId": "s0095",
            "sentence": "The lpxA gene could not be knocked-out in a MC58\u0394mip strain or the complemented MC58\u0394mip::t-nm-mip strain, using either piliated and non-piliated (non-naturally competent) N. meningitidis transformation methods [33].",
            "startOffset": 44557,
            "title": "Expression of a truncated-Nm-MIP protein in the meningococcal OM"
        },
        {
            "endOffset": 52151,
            "parents": [],
            "secId": "s0105",
            "sentence": "The data suggest that the vaccine potential of truncated Ng-MIP proteins should also be examined and that a multi-component vaccine containing a select number of Nm- and Ng-MIP type proteins would be required to provide broad coverage of both pathogens.",
            "startOffset": 51898,
            "title": "Conclusion"
        },
        {
            "endOffset": 31272,
            "parents": [],
            "secId": "s0005",
            "sentence": "In the current study, we extended our studies of the vaccine potential of rT-Nm-MIP by (i) examining the antigenicity of independent batches of experimental vaccines against meningococci and gonococci, (ii) using HC/HS-SBA assays to quantify bactericidal activity against meningococci and gonococci expressing different MIP Type proteins and (iii) attempting to engineer the MenB OM to express truncated MIP.",
            "startOffset": 30864,
            "title": "Introduction"
        },
        {
            "endOffset": 48539,
            "parents": [],
            "secId": "s0100",
            "sentence": "In our study, gonococcal isolates expressing both M10 and M35 proteins were killed.",
            "startOffset": 48456,
            "title": "Discussion"
        },
        {
            "endOffset": 47583,
            "parents": [],
            "secId": "s0100",
            "sentence": "Marginal levels of killing were observed for meningococci expressing M7 protein, which showed a deletion (amino acid residues 28\u201331) and a Ser39Ala change, compared to M2 protein (Fig. 4).",
            "startOffset": 47395,
            "title": "Discussion"
        },
        {
            "endOffset": 49893,
            "parents": [],
            "refoffsets": {
                "b0170": {
                    "endOffset": 49892,
                    "startOffset": 49888
                }
            },
            "secId": "s0100",
            "sentence": "Differential surface expression of Nm-MIP was not a factor (Fig. 5), suggesting several hypotheses: i) MenA and MenY capsules could hinder antibody binding to surface-exposed OM antigens, perhaps associated with capsule structure and density and ii) MIP could be masked by other surface molecules, e.g. other OM proteins and/or different terminal extensions of lipooligosaccharide such as the presence of phosphoethanolamine, enhancing serum-resistance [34].",
            "startOffset": 49435,
            "title": "Discussion"
        }
    ],
    "docId": "S0264410X18307114",
    "metadata": {
        "asjc": [
            "1313",
            "2400",
            "2725",
            "2739",
            "3400"
        ],
        "authors": [
            {
                "email": null,
                "first": "Mar\u00eda Victoria",
                "initial": "M.V.",
                "last": "Humbert"
            },
            {
                "email": "mc4@soton.ac.uk",
                "first": "Myron",
                "initial": "M.",
                "last": "Christodoulides"
            }
        ],
        "doi": "10.1016/j.vaccine.2018.05.069",
        "firstpage": "3926",
        "issn": "0264410X",
        "keywords": [
            "Bactericidal antibody",
            "Human complement",
            "Liposomes",
            "Macrophage Infectivity Potentiator",
            "Neisseria gonorrhoeae",
            "Neisseria meningitidis"
        ],
        "lastpage": "3936",
        "openaccess": "Full",
        "pub_year": 2018,
        "subjareas": [
            "BIOC",
            "IMMU",
            "MEDI",
            "VETE"
        ],
        "title": "Immunization with recombinant truncated Neisseria meningitidis-Macrophage Infectivity Potentiator (rT-Nm-MIP) protein induces murine antibodies that are cross-reactive and bactericidal for Neisseria gonorrhoeae"
    }
}